Your browser doesn't support javascript.
loading
Differential Type-I Interferon Response in Buffy Coat Transcriptome of Individuals Infected with SARS-CoV-2 Gamma and Delta Variants.
da Fonseca, Guilherme C; Cavalcante, Liliane T F; Brustolini, Otávio J; Luz, Paula M; Pires, Debora C; Jalil, Emilia M; Peixoto, Eduardo M; Grinsztejn, Beatriz; Veloso, Valdilea G; Nazer, Sandro; Costa, Carlos A M; Villela, Daniel A M; Goedert, Guilherme T; Santos, Cleber V B D; Rodrigues, Nadia C P; do Couto Motta, Fernando; Siqueira, Marilda Mendonça; Coelho, Lara E; Struchiner, Claudio J; Vasconcelos, Ana Tereza R.
Affiliation
  • da Fonseca GC; Laboratório de Bioinformática, Laboratório Nacional de Computação Científica, Petrópolis, Rio de Janeiro 25651-076, Brazil.
  • Cavalcante LTF; Laboratório de Bioinformática, Laboratório Nacional de Computação Científica, Petrópolis, Rio de Janeiro 25651-076, Brazil.
  • Brustolini OJ; Laboratório de Bioinformática, Laboratório Nacional de Computação Científica, Petrópolis, Rio de Janeiro 25651-076, Brazil.
  • Luz PM; Instituto Nacional de Infectologia Evandro Chagas, FIOCRUZ, Rio de Janeiro 21040-360, Brazil.
  • Pires DC; Instituto Nacional de Infectologia Evandro Chagas, FIOCRUZ, Rio de Janeiro 21040-360, Brazil.
  • Jalil EM; Instituto Nacional de Infectologia Evandro Chagas, FIOCRUZ, Rio de Janeiro 21040-360, Brazil.
  • Peixoto EM; Instituto Nacional de Infectologia Evandro Chagas, FIOCRUZ, Rio de Janeiro 21040-360, Brazil.
  • Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas, FIOCRUZ, Rio de Janeiro 21040-360, Brazil.
  • Veloso VG; Instituto Nacional de Infectologia Evandro Chagas, FIOCRUZ, Rio de Janeiro 21040-360, Brazil.
  • Nazer S; Instituto Nacional de Infectologia Evandro Chagas, FIOCRUZ, Rio de Janeiro 21040-360, Brazil.
  • Costa CAM; Escola Nacional de Saúde Pública, FIOCRUZ, Rio de Janeiro 21041-210, Brazil.
  • Villela DAM; Programa de Computação Científica (PROCC), FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
  • Goedert GT; Escola de Matemática Aplicada (EMAp), Fundação Getúlio Vargas, Rio de Janeiro 22250-900, Brazil.
  • Santos CVBD; Instituto de Medicina Social Hesio Cordeiro (IMS), Universidade do Estado do Rio de Janeiro, Rio de Janeiro 20550-013, Brazil.
  • Rodrigues NCP; Escola Nacional de Saúde Pública, FIOCRUZ, Rio de Janeiro 21041-210, Brazil.
  • do Couto Motta F; Instituto de Medicina Social Hesio Cordeiro (IMS), Universidade do Estado do Rio de Janeiro, Rio de Janeiro 20550-013, Brazil.
  • Siqueira MM; Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-360, Brazil.
  • Coelho LE; Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-360, Brazil.
  • Struchiner CJ; Instituto Nacional de Infectologia Evandro Chagas, FIOCRUZ, Rio de Janeiro 21040-360, Brazil.
  • Vasconcelos ATR; Escola de Matemática Aplicada (EMAp), Fundação Getúlio Vargas, Rio de Janeiro 22250-900, Brazil.
Int J Mol Sci ; 24(17)2023 Aug 24.
Article in En | MEDLINE | ID: mdl-37685953
ABSTRACT
The innate immune system is the first line of defense against pathogens such as the acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The type I-interferon (IFN) response activation during the initial steps of infection is essential to prevent viral replication and tissue damage. SARS-CoV and SARS-CoV-2 can inhibit this activation, and individuals with a dysregulated IFN-I response are more likely to develop severe disease. Several mutations in different variants of SARS-CoV-2 have shown the potential to interfere with the immune system. Here, we evaluated the buffy coat transcriptome of individuals infected with Gamma or Delta variants of SARS-CoV-2. The Delta transcriptome presents more genes enriched in the innate immune response and Gamma in the adaptive immune response. Interactome and enriched promoter analysis showed that Delta could activate the INF-I response more effectively than Gamma. Two mutations in the N protein and one in the nsp6 protein found exclusively in Gamma have already been described as inhibitors of the interferon response pathway. This indicates that the Gamma variant evolved to evade the IFN-I response. Accordingly, in this work, we showed one of the mechanisms that variants of SARS-CoV-2 can use to avoid or interfere with the host Immune system.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferon Type I / Severe acute respiratory syndrome-related coronavirus / COVID-19 Limits: Humans Language: En Journal: Int J Mol Sci Year: 2023 Type: Article Affiliation country: Brazil

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferon Type I / Severe acute respiratory syndrome-related coronavirus / COVID-19 Limits: Humans Language: En Journal: Int J Mol Sci Year: 2023 Type: Article Affiliation country: Brazil